Publications & Presentations * Publications * Clinical * 2017
Clinical Publications 2017

1 One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid- susceptible tuberculosis in Eastern Europe, Western Europe and Latin America. 
D.N. Podlekareva, A. Schultze, A. Panteleev, A.M. Skrahina, J.M. Miro,  A. Rakhmanova, H. Furrer, R.F Miller, A.M. W. Efsen, M.H. Losso, J. Toibaro, A. Vassilenko, E. Girardi, J.D. Lundgren, A. Mocroft, F.A. Post, O. Kirk, on behalf of the TB:HIV study group in EuroCoord.
AIDS. 2017;31(3):375-384. abstract

2 Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study. Hepatitis Coinfection and Non Hodgkin Lymphoma project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
Annals of Internal Medicine. 2017;166(1):9-17. abstract

3 Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.  Standard Reference Distribution of CD4 Response to HAART Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. 
HIV Medicine. 2017;18(1):33-44. abstract

4 Combination antiretroviral therapy and cancer risk. AH Borges
Current Opinion in HIV & AIDS. 2017;12(1):12-19. Abstract

5 Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial. J 
O'Connor, MJ Vjecha, AN Phillips, B Angus, D Cooper, B Grinsztejn, G Lopardo, S Das, R Wood, A Wilkin, H Klinker, P Kantipong, KL Klingman, D Jilich, E Herieka, E Denning, I Abubakar, F Gordin, JD Lundgren; INSIGHT START study group.
Lancet HIV. 2017. pii: S2352-3018(16)30216-8. Abstract

6 Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.

P Ljungman, M Boeckh, HH Hirsch, F Josephson, J Lundgren, G Nichols, A Pikis, RR Razonable, V Miller, PD Griffiths; Disease Definitions Working Group of the Cytomegalovirus Drug Development Forum.
Clinical Infectious Diseases. 20171;64(1):87-91.Abstract

7 An epidemiological modelling study to estimate the composition of HIV-positive populations including migrants from endemic settings. 
F Nakagawa, V Delpech, J Albert, A Alioum, D Bezemer, M Cortina-Borja, AE Brown, V Cambiano, C Campbell, D Costagliola, A de Luca, R Kouyos, R Lodwick, JD Lundgren, N Pantazis, C Smith, V Supervie, P Tookey, G Touloumi, Zh Yin, A van Sighem, AN Phillips
AIDS. 2017;31(3):417-425. Abstract

Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death. M Casadellà; A Cozzi-Lepri; A Phillips; M Noguera-Julian; M Bickel; D Sedlacek; K Zilmer; B Clotet; JD Lundgren; R Paredes, on behalf of EuroSIDA in EuroCoord.
PLoS One. 2017;12(1):e0166613. abstract

9 Is Response to Anti-HCV Treatment Predictive of Mortality in HCV/HIV Positive Patients? Peters L, Cozzi-Lepri A; Hepatitis C Working Group for the Collaboration of Observational HIV Research Europe (COHERE) in EuroCoord.
AIDS. 2017;31(5):661-668.  abstract

10 Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe. Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. 
HIV Med. 2017;18(3):171-180. abstract

11 Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection. AR Lifson, B Grund, EM Gardner, R Kaplan, E Denning, N Engen, CL Carey, F Chen, S Dao, E Florence, J Sanz, S Emery; INSIGHT START Study Group.
AIDS. 2017;31(7):953-963. abstract

12 Late presentation of chronic viral hepatitis for medical care: a consensus definition. S Mauss, S Pol, M Buti , E Duffell, C Gore, JV Lazarus ,HL  der Grient, J Lundgren, A Mozalevskis, D Raben, E Schatz, S Wiktor, JK Rockstroh; European consensus working group on late presentation for Viral Hepatitis Care.
BMC Medicine 2017; 15(1):92 abstract

13 Antiretrovirals, fractures and osteonecrosis in a large international HIV cohort. Borges ÁH, Hoy J, Florence E, Sedlacek D, Stellbrink HJ, Uzdaviniene V, Tomazic J, Gargalianos-Kakolyris P, Schmid P, Orkin C, Pedersen C, Leen C, Pradier C, Mulcahy F, Ridolfo AL, Staub T, Maltez F, Weber R, Flamholc L, Kyselyova G, Lungren JD, Mocroft A; for EuroSIDA.
Clin Infect Dis. 2017;64(10):1413-1421. abstract


1 Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. G Chêne,A Phillips, D Costagliola, JA Sterne, H Furrer, J Del Amo, A Mocroft, A d'Arminio Monforte, F Dabis, JM Miro, D Barger, M Termote, C Schwimmer, R Salbøl Brandt, N Friis-Moller, D Raben, D Haerry, M Egger, I Weller, S De Wit.
International Journal of Epidemiology. 2016. pii: dyw211. Abstract

2 Predictors of eGFR Progression, Stabilisation or Improvement After Chronic Renal Impairment in HIV-positive individuals. L Ryom, A MOcroft, O Kirk, M Ross, C Smith, O Moranne, P Morlat, CA FUX; C Sabin, A Phillips, M Law, JD Lundgren. On behalf of the D:A:D Study group.
AIDS. 2017 Mar 28.  [Epub ahead of print]. abstract